Glycomic immunotherapies

Nature appears to have taken full advantage of the vast diversity of glycans expressed in organisms by evolving protein modules to recognize discrete glycans that mediate specific physiological or pathological processes. Excluding glycan-specific antibodies, GBPs broadly into two major groups such as lectins and glycosaminoglycan-binding proteins. Most lectins are members of families with defined “carbohydrate-recognition domains” (CRDs) that apparently evolved from shared ancestral genes, often retaining specific features of primary amino acid sequence or three-dimensional structure. Thus, new family members can be identified by searching protein sequence or structural databases.

    Related Conference of Glycomic immunotherapies

    August 15-16, 2018

    16th Asia Pacific Biotechnology Congress

    Singapore
    August 27-28, 2018

    5th International Conference on Glycobiology & Glycoproteomics

    Toronto, Ontario, Canada
    August 27-28, 2018

    3rd International Conference on Molecular Biology & Nucleic Acids

    Toronto, Ontario, Canada
    September 17-19, 2018

    4th Glycobiology World Congress

    Rome, Italy
    September 24-26, 2018

    14th International Conference on Structural Biology

    Berlin, Germany
    October 03-04, 2018

    4th International Conference on Biochemistry & Metabolomics

    Los Angeles, California, USA
    October 18-19, 2018

    10th International Congress on Structural Biology

    Helsinki, Finland
    November 19-20, 2018

    15th World Congress on

    Structural Biology

    Paris, France
    February 28-March 01, 2019

    5th International Conference on Enzymology and Protein Chemistry

    Berlin, Germany

    22nd Global Congress on Biotechnology

    February 28-March 02, 2019 Berlin, Germany

    Glycomic immunotherapies Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in